BC
BIIB icon

Brinker Capital’s Biogen BIIB Stock Holding History

Brinker Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$1.61M Buy
+6,028
New +$1.81M 0.05% 364
2018
Q4 		– Sell
-2,562
Closed -$905K – 876
2018
Q3 		$905K Buy
2,562
+224
+10% +$77.1K 0.03% 524
2018
Q2 		$679K Sell
2,338
-229
-9% -$64.4K 0.03% 615
2018
Q1 		$703K Buy
2,567
+100
+4% +$31K 0.03% 593
2017
Q4 		$786K Sell
2,467
-2,680
-52% -$860K 0.03% 527
2017
Q3 		$1.61M Buy
+5,147
New +$1.52M 0.07% 275
2017
Q2 		– Sell
-2,248
Closed -$615K – 675
2017
Q1 		$615K Sell
2,248
-1,248
-36% -$353K 0.03% 544
2016
Q4 		$991K Buy
3,496
+1,396
+66% +$414K 0.06% 307
2016
Q3 		$657K Sell
2,100
-152
-7% -$45K 0.06% 132
2016
Q2 		$545K Sell
2,252
-28
-1% -$7.38K 0.05% 192
2016
Q1 		$593K Buy
2,280
+755
+50% +$199K 0.05% 153
2015
Q4 		$467K Buy
+1,525
New +$438K 0.04% 136
2015
Q3 		– Sell
-15,209
Closed -$6.14M – 118
2015
Q2 		$6.14M Buy
15,209
+13,634
+866% +$5.47M 0.52% 41
2015
Q1 		$665K Sell
1,575
-98
-6% -$38.6K 0.06% 81
2014
Q4 		$568K Buy
1,673
+58
+4% +$18.8K 0.05% 106
2014
Q3 		$534K Buy
1,615
+16
+1% +$5.28K 0.04% 85
2014
Q2 		$504K Buy
1,599
+173
+12% +$52.1K 0.03% 99
2014
Q1 		$436K Sell
1,426
-182
-11% -$57.8K 0.04% 121
2013
Q4 		$449K Sell
1,608
-128
-7% -$33.1K 0.04% 106
2013
Q3 		$417K Buy
1,736
+189
+12% +$42.3K 0.04% 92
2013
Q2 		$332K Buy
+1,547
New +$331K 0.04% 114

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Brinker Capital's BIIB Position: Q2 2020 in Review

Brinker Capital opened a new position in Biogen (BIIB) in Q2 2020: 6,028 shares worth $1.61M. The stake represents 0.05% of the portfolio and ranks #364 among its holdings. This is a return to the name: Brinker Capital previously reported a position in BIIB as recently as Q3 2018.

Brinker Capital first reported a position in BIIB in Q2 2013 and has held it in 21 quarters since. The position peaked at $6.14M in Q2 2015. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q2 2020.

  • Brinker Capital held 6,028 shares of Biogen worth $1.61M as of Q2 2020.
  • Biogen was a new Brinker Capital position in Q2 2020.
  • Biogen made up 0.05% of Brinker Capital's portfolio in Q2 2020, its #364 holding.
  • Brinker Capital first reported a position in Biogen in Q2 2013 and has held it in 21 quarters since.
  • Brinker Capital's Biogen position peaked at $6.14M in Q2 2015.
  • 1,060 funds tracked by Wall St. Rank held Biogen as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.